Bio-Rad Laboratories Down Over 12%, On Pace Largest Percent Decrease Since May 2023 -- Data Talk

Dow Jones
Feb 14

Bio-Rad Laboratories, Inc. Class A $(BIO)$ is currently at $256.04, down $36.38 or 12.44%

 

--Would be lowest close since July 31, 2025, when it closed at $241.95

--On pace for largest percent decrease since May 5, 2023, when it fell 16.72%

--Currently down four of the past five days

--Currently down three consecutive days; down 14.64% over this period

--Worst three day stretch since the three days ending May 9, 2023, when it fell 20.7%

--Down 15.08% this week; worst weekly performance since the week ending Feb. 14, 2025, when it fell 18.99%

--Down 12.82% month-to-date

--Down 15.5% year-to-date

--Down 68.99% from its all-time closing high of $825.77 on Sept. 2, 2021

--Down 7.62% from 52 weeks ago (Feb. 14, 2025), when it closed at $277.16

--Down 24.64% from its 52-week closing high of $339.75 on Oct. 24, 2025

--Up 18.23% from its 52-week closing low of $216.56 on June 2, 2025

--Traded as low as $251.00; lowest intraday level since July 31, 2025, when it hit $241.02

--Down 14.16% at today's intraday low; largest intraday percent decrease since May 5, 2023, when it fell as much as 19.36%

 

All data as of 2:48:51 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 13, 2026 14:52 ET (19:52 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10